Viewing StudyNCT01848106



Ignite Creation Date: 2024-05-06 @ 1:34 AM
Last Modification Date: 2024-10-26 @ 11:06 AM
Study NCT ID: NCT01848106
Status: TERMINATED
Last Update Posted: 2014-10-23
First Post: 2013-05-02

Brief Title: A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI
Sponsor: Regado Biosciences Inc
Organization: Regado Biosciences Inc

Organization Data

Organization: Regado Biosciences Inc
Class: INDUSTRY
Study ID: REG1-CLIN310
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Regado Biosciences Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
The Cleveland Clinic OTHER
Duke Clinical Research Institute OTHER
Canadian VIGOUR Centre OTHER
Icahn School of Medicine at Mount Sinai OTHER
Parexel INDUSTRY